Although a significant trend was observed in MDS‐UPDRS part III scores over time, post hoc comparisons did not confirm significant differences at specific time points.
← all excerpts
Curcumin as a potential therapeutic agent for Parkinson's disease: a systematic review.
2
—
—
The sentences
reported a significant difference in the overall trend of MDS‐UPDRS part III scores between the curcumin and placebo groups over 9 months, although total motor scores and quality-of-life measures did not reach statistical significance.